1. Evaluation of pulmonary hypertension by right heart catheterisation: does timing matter?
- Author
-
Yogeswaran A, Richter MJ, Sommer N, Ghofrani HA, Seeger W, Gall H, and Tello K
- Subjects
- Cardiac Catheterization, Humans, Pulmonary Artery, Hypertension, Pulmonary diagnosis
- Abstract
Competing Interests: Conflict of interest: A. Yogeswaran reports editorial support from University of Giessen, during the conduct of the study. Conflict of interest: M.J. Richter reports grants from German Research Foundation, editorial support from University of Giessen, during the conduct of the study; grants from United Therapeutics, grants and personal fees for lectures and consultancy from Bayer, personal fees for lectures from Actelion, Mundipharma, Roche and OMT, outside the submitted work. Conflict of interest: N. Sommer reports personal fees from Actelion, outside the submitted work. Conflict of interest: H.A. Ghofrani reports grants from German Research Foundation, editorial support from University of Giessen, during the conduct of the study; personal fees for consultancy and advisory board work from Bayer and Pfizer, personal fees for consultancy, lectures and advisory board work from Actelion and GSK, personal fees for consultancy from Merck, grants and personal fees for consultancy from Novartis, grants and personal fees for lectures from Bayer HealthCare and Encysive/Pfizer, grants from Aires, German Research Foundation, Excellence Cluster Cardiopulmonary Research and German Ministry for Education and Research, personal fees for advisory board work from Takeda, outside the submitted work. Conflict of interest: W. Seeger reports grants from German Research Foundation, editorial support from University of Giessen, during the conduct of the study; personal fees for lectures and consultancy from Pfizer and Bayer Pharma AG, outside the submitted work. Conflict of interest: H. Gall reports grants from German Research Foundation, editorial support from University of Giessen, during the conduct of the study; personal fees from Actelion, AstraZeneca, Bayer, BMS, GSK, Janssen-Cilag, Lilly, MSD, Novartis, OMT, Pfizer and United Therapeutics, outside the submitted work. Conflict of interest: K. Tello reports grants from German Research Foundation, editorial support from University of Giessen, during the conduct of the study; personal fees for lectures from Actelion and Bayer, outside the submitted work.
- Published
- 2020
- Full Text
- View/download PDF